Eighty-nine subjects with PCOS and IR subjects were randomized into one of three treatment groups : BBR + compound cyproterone acetate ( CPA ; n = 31 ) , MET+CPA ( n = 30 ) , and placebo + CPA ( n = 28 ) for 3 months .
